{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:50:24Z","timestamp":1780516224946,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PDC2022-133706-I00"],"award-info":[{"award-number":["PDC2022-133706-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["PID2021-128047NB-I00"],"award-info":[{"award-number":["PID2021-128047NB-I00"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["2023-2028"],"award-info":[{"award-number":["2023-2028"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007757","name":"Agencia Canaria de Investigaci\u00f3n, Innovaci\u00f3n y Sociedad de la Informaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007757","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijpddr.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:20:00Z","timestamp":1685499600000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["In vitro activity and mechanism of cell death induction of cyanomethyl vinyl ethers derivatives against Trypanosoma cruzi"],"prefix":"10.1016","volume":"22","author":[{"given":"Carlos J.","family":"Bethencourt-Estrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Delgado-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atteneri","family":"L\u00f3pez-Arencibia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"San Nicol\u00e1s-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-6289","authenticated-orcid":false,"given":"Fernando","family":"Garc\u00eda-Tellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lorenzo-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actatropica.2010.03.002","article-title":"Research needs for Chagas disease prevention","volume":"115","author":"Abad-Franch","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/molecules14062256","article-title":"Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs","volume":"14","author":"Ancizu","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.3390\/molecules17089451","article-title":"Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives","volume":"17","author":"Barea","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1128\/AAC.49.12.5160-5161.2005","article-title":"A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi","volume":"49","author":"Barr","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1051\/parasite\/2019071","article-title":"Cell death in leishmania","volume":"26","author":"Basmaciyan","year":"2019","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007264","article-title":"(De)glutamylation and cell death in Leishmania parasites","volume":"13","author":"Basmaciyan","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-1999-14012","article-title":"Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo","volume":"65","author":"Bastos","year":"1999","journal-title":"Planta Med."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.bmcl.2010.10.015","article-title":"Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease","volume":"20","author":"Beaulieu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/605091","article-title":"An estimate of the burden of Chagas disease in the United States","volume":"49","author":"Bern","year":"2009","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ph14060552","article-title":"Acrylonitrile derivatives against trypanosoma cruzi: in vitro activity and programmed cell death study","volume":"14","author":"Bethencourt-Estrella","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105872","article-title":"In vitro activity and cell death mechanism induced by acrylonitrile derivatives against Leishmania amazonensis","volume":"124","author":"Bethencourt-Estrella","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005343","article-title":"Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors","volume":"11","author":"Burtoloso","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/1566524043360249","article-title":"The determinants of Chagas disease: connecting parasite and host genetics","volume":"4","author":"Campbell","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040657","article-title":"Antikinetoplastid activity of indolocarbazoles from Streptomyces sanyensis","volume":"10","author":"Cartuche","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bmc.2019.02.039","article-title":"Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi","volume":"27","author":"Chao","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"Suppl. l","key":"10.1016\/j.ijpddr.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed--a background article","volume":"102","author":"Coura","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/np401060j","article-title":"Dimeric flavonoids from Arrabidaea brachypoda and assessment of their anti-Trypanosoma cruzi activity","volume":"77","author":"da Rocha","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144120","article-title":"Cyanovinylation of aldehydes: organocatalytic multicomponent synthesis of conjugated cyanomethyl vinyl ethers","volume":"26","author":"Delgado-Hern\u00e1ndez","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2019.100507","article-title":"Chagas disease: chronic Chagas cardiomyopathy","volume":"46","author":"Echavarr\u00eda","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ejmech.2017.10.056","article-title":"Indole and benzimidazole bichalcophenes: synthesis, DNA binding and antiparasitic activity","volume":"143","author":"Farahat","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4155\/fmc-2020-0057","article-title":"Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds","volume":"13","author":"Fonseca Lameiro","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2018.04.009","article-title":"Activity in vitro and in vivo against Trypanosoma cruzi of a furofuran lignan isolated from Piper jericoense","volume":"189","author":"Garc\u00eda-Huertas","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmc.2006.01.007","article-title":"Indazole N-oxide derivatives as antiprotozoal agents: synthesis, biological evaluation and mechanism of action studies","volume":"14","author":"Gerpe","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.semdp.2019.04.008","article-title":"Chagas disease as example of a reemerging parasite","volume":"36","author":"Guarner","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.bmc.2013.01.050","article-title":"Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi","volume":"21","author":"Keenan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fmicb.2018.00269","article-title":"Circulating plasma MicroRNA-208a as potential biomarker of chronic indeterminate phase of Chagas disease","volume":"9","author":"Linhares-Lacerda","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s13071-019-3854-4","article-title":"In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death","volume":"12","author":"L\u00f3pez-Arencibia","year":"2019","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib29","volume":"vol. 8","author":"L\u00f3pez-Arencibia","year":"2019"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121219","article-title":"Discovery of new chemical tools against leishmania amazonensis via the MMV pathogen box","volume":"14","author":"L\u00f3pez-Arencibia","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/np1008043","article-title":"In vitro and in vivo trypanocidal activity of flavonoids from Delphinium staphisagria against Chagas disease","volume":"74","author":"Mar\u00edn","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/jac\/dkaa030","article-title":"Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease","volume":"75","author":"Mart\u00edn-Escolano","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41419-019-1370-2","article-title":"Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill","volume":"10","author":"Menna-Barreto","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0140-6736(81)92518-6","article-title":"Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian forms of Chagas' disease?","volume":"1","author":"Miles","year":"1981","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.01544-06","article-title":"Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth","volume":"51","author":"Mishina","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01936-17","article-title":"In vitro and in vivo studies of the trypanocidal effect of novel quinolines","volume":"62","author":"Nefertiti","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02236-20","article-title":"In vitro susceptibility of kinetoplastids to celastroloids from Maytenus chiapensis","volume":"65","author":"N\u00fa\u00f1ez","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib38","article-title":"Chagas disease in the Americas: a review of the current public health situation and a vision for the future","author":"Organization","year":"2018","journal-title":"Rep. conclusions Recomm."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ejmech.2016.08.002","article-title":"Nitrotriazole-based acetamides and propanamides with broad spectrum antitrypanosomal activity","volume":"123","author":"Papadopoulou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2020.108032","article-title":"Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection","volume":"219","author":"Quilles","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/00034983.1983.11811668","article-title":"The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica","volume":"77","author":"Raether","year":"1983","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/hrt.2008.159624","article-title":"Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease","volume":"95","author":"Rassi","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib44","first-page":"275","article-title":"American trypanosomiasis (Chagas disease)","volume":"26","author":"Rassi","year":"2012","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib45","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.gheart.2015.06.001","article-title":"The burden of Chagas disease: estimates and challenges","volume":"10","author":"Stanaway","year":"2015","journal-title":"Glob. Heart"},{"key":"10.1016\/j.ijpddr.2023.05.001_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/CMR.5.4.400","article-title":"Chagas' disease","volume":"5","author":"Tanowitz","year":"1992","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib48","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.bmcl.2006.07.042","article-title":"Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro","volume":"16","author":"Torrence","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2023.05.001_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","article-title":"In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease","volume":"21","author":"Urbina","year":"2003","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320723000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320723000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:53:26Z","timestamp":1761922406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320723000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":50,"alternative-id":["S2211320723000167"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2023.05.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity and mechanism of cell death induction of cyanomethyl vinyl ethers derivatives against Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}